Literature DB >> 19287210

Monocyte attachment to laminin in diabetes mellitus: The role of ATP.

Elena Kostidou1, Varvara Trachana, Konstantina Topouridou, Konstantinos Paletas, Apostolos Tsapas, Martha Kaloyianni, George Koliakos.   

Abstract

Monocyte-extracellular matrix interactions have been implicated in atherosclerosis pathophysiology. Laminin, the main basement membrane protein contains cell binding domains that can be cryptic, presented only after protein modification. In the present study we evaluated monocyte attachment to laminin-1 in the presence of ATP. Monocytes were derived from either healthy volunteers or patients with diabetes mellitus type II. For the estimation of monocyte attachment to laminin the myeloperoxidase assay was used. Monocytes derived from diabetic patients, showed an increased ability to attach to laminin (p = 0.0055). The presence of ATP increased the attachment of control monocytes to laminin (p = 0.0022). On the contrary, the presence of ATP did not affect the attachment of monocytes derived from diabetic patients to laminin. Our results indicate a modified interaction between monocytes and laminin-1 in diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19287210      PMCID: PMC2679874          DOI: 10.4161/cam.3.2.8207

Source DB:  PubMed          Journal:  Cell Adh Migr        ISSN: 1933-6918            Impact factor:   3.405


  22 in total

1.  Restricted distribution of laminin alpha1 chain in normal adult mouse tissues.

Authors:  M Falk; M Ferletta; E Forsberg; P Ekblom
Journal:  Matrix Biol       Date:  1999-12       Impact factor: 11.583

2.  Laminin--a glycoprotein from basement membranes.

Authors:  R Timpl; H Rohde; P G Robey; S I Rennard; J M Foidart; G R Martin
Journal:  J Biol Chem       Date:  1979-10-10       Impact factor: 5.157

3.  Phosphorylation of laminin-1 by protein kinase C.

Authors:  G Koliakos; V Trachana; M Gaitatzi; A Dimitriadou
Journal:  Mol Cells       Date:  2001-04-30       Impact factor: 5.034

4.  Laminin selectively enhances monocyte-macrophage-mediated tumoricidal activity.

Authors:  R T Perri; G Vercellotti; J McCarthy; R L Vessella; L T Furcht
Journal:  J Lab Clin Med       Date:  1985-01

5.  CD11b/CD18 mediates production of reactive oxygen species by mouse and human macrophages adherent to matrixes containing oxidized LDL.

Authors:  J Husemann; A Obstfeld; M Febbraio; T Kodama; S C Silverstein
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-08       Impact factor: 8.311

6.  Alpha2beta1 integrin and development of atherosclerosis in a mouse model: assessment of risk.

Authors:  David G Grenache; Trey Coleman; Clay F Semenkovich; Samuel A Santoro; Mary M Zutter
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-09-25       Impact factor: 8.311

7.  Laminin-1 is phosphorylated by ecto-protein kinases of monocytes.

Authors:  Varvara Trachana; Efthymios Christophorides; Kokkona Kouzi-Koliakos; George Koliakos
Journal:  Int J Biochem Cell Biol       Date:  2005-02       Impact factor: 5.085

8.  Selectins and monocyte chemotactic peptide as the markers of atherosclerosis activity.

Authors:  M Bláha; J Krejsek; V Bláha; J Andrýs; D Vokurková; J Malý; M Blazek; M Skorepová
Journal:  Physiol Res       Date:  2004       Impact factor: 1.881

9.  Enhanced laminin carbonylation by monocytes in diabetes mellitus.

Authors:  Elena Kostidou; George Koliakos; Daryoush Hamidi Alamdari; Konstantinos Paletas; Apostolos Tsapas; Martha Kaloyianni
Journal:  Clin Biochem       Date:  2007-03-28       Impact factor: 3.281

Review 10.  Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals.

Authors:  Kiyoshi Takahashi; Motohiro Takeya; Naomi Sakashita
Journal:  Med Electron Microsc       Date:  2002-12
View more
  1 in total

1.  A novel monocyte differentiation pattern in pristane-induced lupus with diffuse alveolar hemorrhage.

Authors:  Shuhong Han; Haoyang Zhuang; Rawad Daniel Arja; Westley H Reeves
Journal:  Elife       Date:  2022-10-20       Impact factor: 8.713

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.